Objectives: To estimate the effectiveness of detoxification in multi-resistant chronic migraine (CM) with medication overuse headache (MOH) patients who start prophylaxes with Botulinum Toxin A(BTA) or Anti-CGRP mAb. This evidence concerns the gene CALCA and cutaneous mastocytosis.